[Polymyositis and dermatomyositis in childhood].
Authors report clinical and laboratory findings, treatment and evolution of six girls and three boys aged between 20 months and 13 years, diagnosed of juvenile polymyositis-dermatomyositis in the last seven years. Presenting symptoms were asthenia and proximal muscle weakness; in 3 cases characteristic skin lesions were associated. All were treated initially with prednisone p.o. (1-2 mg/kg/day) response being favourable in seven. Two patients with chronic evolution were treated with methotrexate and IV bolus of methylprednisolone.
Rodríguez Núñez
A
A
Departamento de Pediatría, Hospital General de Galicia, Facultad de Medicina, Universidad de Santiago de Conpostela.
Fernández Bustillo
J M
JM
Rodríguez Pérez
E
E
Novo Rodríguez
I
I
Pérez Becerra
E
E
Peña Guitián
J
J
Castro Gago
M
M
D000293:Adolescent; D002114:Calcinosis / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D003882:Dermatomyositis / Q000150:complications / Q000188:drug therapy / Q000473:pathology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D007275:Injections, Intravenous; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008775:Methylprednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use
D011241:Prednisone; D008775:Methylprednisolone; D008727:Methotrexate
Poliomiositis y dermatomiositis en la infancia.